Our Story

 

LEARN, DISCOVER AND NETWORK WITH
IMMUNO-ONCOLOGY EXPERTS

 

The 4th Immuno-Oncology Profiling Congress will bring together high level, global speakers from big pharma, biotech, academia and industry to discuss the clinical and commercial aspects that are impacting the reality of incorporating the precision medicine approach into immuno-oncology. Explore the latest methods and technologies that allow better understanding of the immune system, and improve therapeutic design and treatment strategies in cancer immunotherapy.
 

Hear clinical trial updates and discuss the importance of a collaborative approach to advance cancer treatment. Alongside, joining in discussions on how immune profiling & bioinformatics techniques can be integrated with break through immunotherapy approaches like Antibody Therapies, Adoptive T-Cell Therapies, NK Cell Therapies, personalized Cancer Vaccines, Oncolytic Virus’ and combinations.
 

We bring you 3 days packed full of top level science, data and case studies, workshops, roundtables and networking opportunities. Co-located with the 20th World Vaccine Congress, the event connects infectious disease immunologists with cancer experts to help accelerate research & development and collaboration. With 175+ speakers, 600+ attendees and hundreds of companies in attendance, this is not an event to be missed.

IMMUNOTHERAPY APPROACHES & COMBINATION STRATEGIES

  • Discover how Antibody Therapies, Adoptive T-Cell Therapies, NK Cell Therapies, personalized Cancer Vaccines & Oncolytic Virus therapies are advancing clinically from leading biotechs, pharma & academics.
  • With every trial becoming combinational, the distinction between different immunotherapy treatments is merging – learn how your treatment can be integrated into other indications for better clinical efficacy and patient outcome

 

IMMUNE PROFILING IN CANCER

  • Immunosequencing: Combining high throughput sequencing and bioinformatics to profile T-cell and B-cell receptors
  • Single-cell technologies: Validating discoveries and translating them into clinically useful diagnostic assays
  • Technological advancements in tumour microenvironment profiling & methods to overcome immunosuppression

 

BIG DATA IN ONCOLOGY

  • In the precision medicine era of immuno-oncology, a key area of study is discovering new ways to monitor the effectiveness of immunotherapy treatments.
  • Discover how Big Data is being used to predict immunotherapy responses, model cancer pharmacogenomics & enable the rational design of combinatorial immunotherapy for patient treatment.

 

 

 

 

 

 

 

BIOMARKERS & PATIENT SELECTION

  • The success of immune checkpoint inhibitors in a subset of cancer patients has led to major efforts in identifying predictive biomarkers, but there is also a need for creating a reference standard for biomarker assays.
  • Learn how big pharma are collaborating to create these reference standards and how they plan to facilitate pre-competitive information sharing
  • Emerging Biomarker: MICROBIOME and its use as a biomarker for cancer detection or progression

 

BRIDGING INFECTIOUS DISEASE & CANCER

  • Co-located with the World Vaccine Congress, the event connects infectious disease immunologists with cancer experts to help accelerate research & development and collaboration
  • There is significant crossover between infectious disease and cancer when it comes to immune characterisation, interplay with T/B cells, multifaceted technology platforms, vaccine & antibody design
 

THE IMMUNO-ONCOLOGY PROFILING CONGRESS WILL:

Provide a marketplace where the world's leading companies from sequencing, research, biotech, assay & biomarker, bioanalytical & Data, technology and device manufacturers can showcase their services and cancer products to decision makers.

Provide delegates one stop progressive scientific and strategic solutions to the immuno-oncology industry, through executive level commentary, case studies and real time analysis from key stakeholders to bring about faster, more cost-effective and more efficacious cancer treatments.

Create a valuable marketplace for pharma and biotech involved in immuno-oncology to source and compare products and services that will help them.

Explore the latest methods of characterisation, identifying biomarkers and surrogate markers, immunosequencing, high throughput analysis and interpretation of omics data and immune-oncology.

Bring senior executive heads of Immunology, Translational and Immuno-Oncology, Predictive Medicine, Research, Sequencing / Next gen sequencing, Cancer Immunotherapy, Bioinformatics, Biomarker Discovery & Diagnostics Translational Science and Adjuvants to network F2F.

Showcase C-Level executives from all the key developers and thought leaders from pharma, biotech’s, academics and government, in a combined scientific and commercial environment where service providers can do business.

 

FOR WORLD-CLASS SOLUTION PROVIDERS

The Immuno-Oncology Profiling Congress offers outstanding opportunities for service and solution providers, from senior sponsorship to a range of exhibition booths. If you are looking to gain access to key vaccine decision makers then this is your best ROI in 2019.

 

 




Very good organization, interesting mix of talks, good balance between panels and parallel tracks


Head R&D, Marburg GSK Vaccines



 

 

Sign Up for Event Updates